News | March 19, 2014

Hokkaido University, Hitachi Develop Proton Beam Therapy System

Hitachi Probeat-RT Proton Beam Therapy System Radiation Therapy

March 19, 2014 — Hokkaido University and Hitachi Ltd. completed construction of facilities incorporating the Probeat-RT Proton Beam Therapy System within the Hokkaido University Hospital. Hokkaido University and Hitachi had been jointly developing the Probeat–RT. The project was awarded a grant in 2010 under the Funding Program for World-Leading Innovative R&D on Science and Technology (the “FIRST Program”), a national project sponsored by the Japanese government. The University plans to begin treatments using the newly constructed facilities March 19, 2014.

The FIRST Program is a major research support structure established as part of a Japanese government initiative to promote science and technology. 30 out of 565 applicant "Core Researchers and Projects" were awarded grants based on their notable potential in the advancement of Japanese science and technology in March 2010. Hokkaido University's "Advanced Radiation Therapy Project Real-time Tumor-tracking with Molecular Imaging Technique" project was awarded a FIRST grant following an application by Hiroki Shirato, department of radiation medicine, Graduate School of Medicine. This was the only application accepted in the field of radiation therapy. The goal of “Advanced Radiation Therapy Project Real-time Tumor-tracking with Molecular Imaging Technique” is to develop a treatment system that can dramatically reduce the irradiation of normal tissue, in a compact, low-cost system that demonstrates international competitiveness. This goal is achieved by combining the Real-time Tumor –tracking Radiation Therapy developed by Hokkaido University through X-ray therapy with Hitachi’s spot scanning proton beam irradiation technology. In this way, Hokkaido University and Hitachi will offer a proton beam therapy system that can accurately irradiate a tumor that moves due to respiration, for example in the lung and liver.

At the recently completed facility, Hokkaido University will provide treatment using spot scanning irradiation technology from Hitachi and strive to quickly develop a treatment system that incorporates its own moving tumor tracking irradiation technology. Hitachi has already applied for approval for manufacture and sales of the treatment system combining spot scanning irradiation and Real-time Tumor-tracking Radiation Therapy. It hopes to receive approval and begin treatments in the first half of FY 2014.

By merging technologies and expertise, the system reduces the size of the gantry, the irradiation nozzle and the accelerator. In this approach, they have created a treatment system that is easy to use and more compact overall. In comparison to the Probeat-III Proton Beam Therapy System, which was released previously by Hitachi, the circumference of the accelerator has been reduced to 18 m from the original 23 m; the gantry, which had a maximum external length of 11 m and an internal diameter of 3.5 m, has been reduced in size to a maximum external length of 9 m and an internal diameter of 2.5 m. The installation area required for the system as a whole has been reduced by approximately 30 percent.

In “Real-time Tumor Tracking Radiation Therapy,” gold markers are inserted in the proximity of the tumor, and a computed tomography (CT) system is used to identify the marker positions in relation to the tumor core. Using an X-ray fluoroscopy system from two directions, this technology automatically pinpoints the gold markers positions on a fluoroscopy image using pattern recognition, and repeatedly calculates the spatial position at regular intervals. The treatment beam only irradiates the targeted tumor when the gold markers are located within a few millimeters of the planned positions. As this operation is performed at high speed, it is possible to irradiate tumors with a high degree of accuracy, even when they move within the body, for example due to the patient’s respiration. Compared to conventional methods that irradiate the entire area in which the tumor might migrate, this system reduces the irradiation volume by 50-75 percent, allowing a reduction in the irradiation of normal tissue.

Hitachi’s Spot scanning irradiation technology uses a constant, narrow beam, repeatedly turning this beam on and off at high speed as it progressively changes location. In this way, the beams can be targeted with high precision according to the shape of the tumors, even if those shapes are extremely complex, thus minimizing the impact on normal tissue.

For more information: www.oia.hokudai.ac.jp, www.hitachi.com

Related Content

Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
Cleveland Clinic Researchers Reveal Biomarker for Guiding Prostate Cancer Treatment
News | Prostate Cancer | October 17, 2017
October 17, 2017 — Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-r
IBA Announces First Use of Gating With Active Scanning Proton Therapy in Italy
News | Proton Therapy | October 17, 2017
October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful comp
Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation Therapy, MRI guided RT.
Sponsored Content | Webinar | Radiation Therapy | October 13, 2017
The webinar "Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation" will be presented by Par
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key th
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains ho
Overlay Init